ALVA (Pep-back ultra caffeine (anhydrous) 200 mg)
Generic Name: caffeine
Pill imprint ALVA has been identified as Pep-back ultra caffeine (anhydrous) 200 mg.
Pep-Back Ultra is used in the treatment of hypersomnia; apnea of prematurity and belongs to the drug class CNS stimulants. Caffeine Citrate Injection: Risk cannot be ruled out during pregnancy. Excluding Caffeine Citrate Injection: FDA has not classified the drug for risk during pregnancy. Pep-Back Ultra caffeine (anhydrous) 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- caffeine (anhydrous) 200 mg
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out - Caffeine Citrate Injection
N - Not classified - excluding Caffeine Citrate Injection
- CSA Schedule:
- Not a controlled drug
- Alva-Amco Pharmacal Companies, Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium carbonate
calcium sulfate dihydrate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
polyethylene glycol 600
sodium lauryl sulfate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about Pep-Back Ultra (caffeine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.